1/95
Key vocabulary terms and concise definitions drawn from the lecture notes on innate and acquired immunity, cellular players, antigen concepts, the complement system, immunoglobulins, cytokines, and immunopotentiation.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Immunology
The study of the body's defense mechanisms against foreign pathogens and aberrant self-cells, including organs, cells, and molecules of the immune system.
Immune components
Organs, cells (e.g., lymphocytes), and molecules (e.g., antibodies) that constitute the immune system.
Host-microbial relationship
Factors influencing infection, including microbial factors and host factors that determine disease outcome.
Specificity
Each pathogen causes a distinct disease, reflecting a unique host-pathogen interaction.
Koch’s postulates
Five criteria to establish causation: (1) pathogen in all cases, (2) isolated in pure culture, (3) causes disease in susceptible hosts, (4) re-isolatable from infected hosts, (5) detectable specific antibodies in host serum.
Exceptions to Koch’s postulates
Examples where postulates don’t hold: Neisseria gonorrhoeae (no good animal model) and Mycobacterium leprae (unculturable in vitro).
Infectivity
Pathogen’s ability to invade, colonize, and multiply within a host.
Reservoirs
Sources from which a pathogen maintains itself: endogenous (within the host) or exogenous (external) reservoirs.
Endogenous reservoir
Commensals or other organisms from the host that become pathogenic.
Exogenous reservoir
Pathogens sourced outside the host, including humans, animals, environment, or vectors.
Carrier
A person who carries pathogenic organisms and transmits them without showing symptoms.
Carrier types
Healthy (asymptomatic), incubatory (before symptoms), and convalescent (recovery) carriers.
Transmission routes
Ways pathogens spread: Airborne, Oral, Vector-borne, Contact (direct/indirect), and Parenteral.
Airborne transmission
Spread via droplets or aerosols that are inhaled.
Oral transmission
Ingestion of contaminated food or water.
Vector-borne transmission
Transmission by vectors such as insects (e.g., malaria via mosquitoes).
Contact transmission
Direct contact or contact with contaminated surfaces (fomites).
Parenteral transmission
Pathogens transmitted by wounds or injections bypassing the gut.
Invasiveness
Pathogen’s capacity to penetrate host tissues.
Invasive mechanisms
Strategies used by pathogens: enzymes (hyaluronidase, collagenase) and anti-phagocytic structures (capsules, M-proteins), plus intracellular survival (e.g., M. tuberculosis).
Pathogenicity
Ability of a microorganism to cause disease.
Virulence
Degree of pathogenicity or how severe the disease is.
Infective dose
Amount of pathogen required to establish infection.
MLD (Minimal Lethal Dose)
Dose that kills 100% of hosts in a given test.
LD50
Dose that kills 50% of hosts in a given test.
Exotoxin
Toxin secreted by Gram-positive bacteria that harms the host.
Endotoxin
Toxic component of Gram-negative bacterial cell walls (e.g., LPS).
Innate immunity
Non-specific natural defenses present at birth that act quickly.
Acquired (adaptive) immunity
Specific immune response developed after exposure to antigens, with memory.
Passive acquired immunity
Immunity transferred from another source (natural: transplacental, lactation; artificial: antitoxins, gamma globulins).
Active acquired immunity
Immunity generated by an individual’s own immune response after exposure to an antigen (natural infection or artificial vaccination).
T-independent antigens
Antigens (often polysaccharides) that stimulate B cells without T cell help; often multivalent.
T-dependent antigens
Antigens (usually proteins) requiring T cell help to activate B cells.
Hapten
Incomplete antigen that is antigenic but not immunogenic unless attached to a larger carrier protein.
Immunogenic vs antigenic
Immunogenic substances elicit an immune response; antigens are recognized by the immune system but may not be immunogenic on their own.
Autoantigen
An antigen derived from the host’s own tissues.
Isoantigen
Antigen present in genetically identical individuals (e.g., identical twins).
Alloantigen
Antigen present in genetically different members of the same species.
Xenoantigen
Antigen from a different species.
Epitope
The part of an antigen that is recognized by an antibody (antibody-binding site).
Valency
Number of epitopes available on an antigen to which antibodies can bind.
Affinity
Strength of the attraction between a single antigen epitope and an antibody combining site.
Avidity
Overall strength of multiple binding interactions between a multivalent antigen and antibody.
Immunogenicity
Ability of a substance to provoke an immune response.
Factors influencing immunogenicity: Foreignness
How different the substance is from the host, increasing immune recognition.
Factors influencing immunogenicity: Molecular size
Larger molecules are generally more immunogenic.
Factors influencing immunogenicity: Chemical complexity
More complex molecules (e.g., proteins) tend to be more immunogenic.
Factors influencing immunogenicity: Physical form
Particulate antigens are usually more immunogenic than soluble ones.
Factors influencing immunogenicity: Degradability
Easily degradable antigens are typically more immunogenic.
Central lymphoid organs
Organs where immune cells develop: bone marrow and thymus.
Peripheral lymphoid organs
Organs where immune responses occur: lymph nodes, spleen, MALT.
Spleen
Filters blood, removes aged red cells, conducts phagocytosis and immunoglobulin synthesis.
Mucosa-associated lymphoid tissue (MALT)
Lymphoid tissue in mucosal sites contributing to mucosal immunity.
Antigen
A substance capable of stimulating an immune response; forms include complete immunogens and haptens.
Complete antigen (immunogen)
Antigen that induces an immune response and is reactive with specific antibodies or lymphocytes.
Incomplete antigen (hapten)
Small molecule that is antigenic but immunogenic only when coupled to a larger carrier.
Autoantigen/ Isoantigen/ Alloantigen/ Xenoantigen
Different classes of antigens based on origin: self, genetically identical, genetically different within species, or from a different species.
Determinant groups of antigen (epitopes)
Sites on antigens that antibodies recognize; determine antigen specificity and may be multivalent.
Affinity constant (paratope-antigen binding)
Measure of the strength of a single antigen-antibody interaction.
Immunogenicity determinants
Factors like foreignness, size, complexity, cross-reactivity, and degradability influence immunogenicity.
T-independent antigens vs T-dependent antigens
T-independent: activate B cells without T cells (often polysaccharides); T-dependent: require T cell help (proteins).
B cells vs T cells
B cells produce antibodies; T cells mediate cellular immunity and help B cells; both have distinct receptors and functions.
MHC/HLA
Major histocompatibility complex; gene complexes that present processed antigens to T cells (Class I to CD8, Class II to CD4; Class III includes complement proteins).
Class I MHC
MHC molecules expressed on all nucleated cells; present antigens to CD8+ T cells.
Class II MHC
MHC molecules on antigen-presenting cells (B cells, dendritic cells, Th); present to CD4+ T cells.
Class III MHC
Genetic region encoding several immune-related proteins, including some complement components.
Immunoglobulin (Ig)
Antibodies; glycoproteins produced by plasma cells derived from B cells; recognize specific antigens.
Light chain (κ and λ)
Two types of light chains in Ig molecules; paired with heavy chains to form the antigen-binding site.
Heavy chain types (IgG, IgA, IgM, IgD, IgE)
Different constant regions defining antibody classes with distinct functions and distributions.
Fab and Fc fragments
Fab contains the antigen-binding region; Fc mediates effector functions (e.g., complement, Fc receptors).
Hinge region
Flexible region in Ig molecules allowing binding to antigens with multiple epitopes.
IgG
Major serum Ig (75%); crosses placenta; fixes complement (except IgG4); predominant in secondary responses; opsonizes.
IgA
Present in serum and secretions; secretory IgA protects mucosal surfaces; forms secretory piece.
IgM
First antibody produced in primary response; pentameric; strong complement activator.
IgD
Low-abundance Ig; functions as B cell receptor on naive B cells.
IgE
Reagin antibody; mediates immediate hypersensitivity; binds to mast cells and basophils.
Opsonization
Coating of a pathogen with antibodies/complement to enhance phagocytosis.
Complement system
Group of heat-labile proteins that assist immunity; activation leads to lysis, chemotaxis, opsonization, and inflammation.
Classical pathway (complement)
Activation via antibodies (IgG/IgM) binding to antigen, leading to sequential C1–C9 activation.
Alternative pathway (complement)
Activation triggered directly by microbial surfaces, independent of antibodies.
Membrane attack complex (MAC)
Final assembly (C5b–C9) that forms pores in target cell membranes.
MHC/HLA roles
Antigen presentation, graft rejection/compatibility, disease associations, and diagnostic use.
Immunopotentiation
Enhancement of immune responses, often using adjuvants or immune stimulants.
Adjuvants
Substances that boost immune responses to an antigen (e.g., Freund’s adjuvant, aluminum hydroxide, BCG).
Freund’s adjuvant (incomplete vs complete)
Incomplete adjuvant: oil–water mix; complete adjuvant adds bacterial components to enhance response.
Transfer factor
A preparation claimed to transfer immune knowledge between cells to boost response.
Interferons (IFN)
Cytokines that inhibit viral replication and modulate immune responses (Type I: IFN-α/β; Type II: IFN-γ).
Interleukins (IL-1, IL-2, IL-4, IL-5, IL-6)
Cytokines with specific roles in fever, T and B cell activation, and acute-phase responses.
TNF-α/TNF-β
Cytokines with roles in inflammation, cytotoxicity, and tumor cell killing.
GM-CSF
Granulocyte–macrophage colony-stimulating factor; promotes growth of white blood cells.
NK cells (Natural Killer)
Lymphocytes that kill virus-infected or tumor cells without antibody help; part of innate immunity.
ADCC (antibody-dependent cellular cytotoxicity)
Killing of antibody-coated target cells by effector cells (e.g., NK cells) via Fc receptors.
Cytokines in T cell help
IL-2, IL-4, IL-5 mediate T cell proliferation and B cell help; Th cells orchestrate responses.
Immunosuppression
Deliberate reduction of immune activity to prevent rejection, treat autoimmune disease, or control inflammation.
Immunosuppressive methods
Physical removal of immune organs, radiation, or drugs that inhibit T/B cells (e.g., anti-thymocyte serum, methotrexate, cyclosporine, steroids).
Monoclonal antibodies
Antibodies derived from a single B cell clone with identical specificity; used in research and therapy.